ML

Mary Kay Ladone

Board Member at Bioventus

Mary Kay Ladone, an accomplished executive serving large global health care companies over her 30+ year career, is currently Corporate Officer, Senior Vice President, Corporate Development, Strategy & Investor Relations, Hill-Rom Holdings, Inc (Hillrom). She joined Hillrom as Vice President and Investor Relations Officer in 2016.

Previously, Ladone served as Senior Vice President and Corporate Officer, Investor Relations of Baxalta, Inc., a global biopharmaceutical company spun out from Baxter International in 2015. She began her career in Finance at Baxter International, Inc., and went on to serve in several progressive financial, operational and communication roles at the company. Ladone was promoted to Corporate Vice President and Corporate Officer, Investor Relations, and led Baxter’s investor relations program from 2004 to 2015.

Ladone has consistently been recognized by the investment community as a top investor relations professional, including numerous designations by Institutional Investor. She has also served on the Board of Trustees of Edward-Elmhurst Health System since 2009 as a member and/or chair of the Executive, Finance and Investment Committee, and held the position of Vice Chairman of Edward Health Services Corporation from 2012 to 2013.

Ladone received a Bachelor of Business Administration degree (Finance & Business Economics) cum laude from the University of Notre Dame.

Timeline

  • Board Member

    Current role